- Home
- ETWO vs CATX Comparison
ETWO vs CATX Comparison
Compare ETWO & CATX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ETWO
- CATX
- Stock Information
- Founded
- ETWO 2000
- CATX 1983
- Country
- ETWO United States
- CATX United States
- Employees
- ETWO N/A
- CATX N/A
- Industry
- ETWO EDP Services
- CATX Medical/Dental Instruments
- Sector
- ETWO Technology
- CATX Health Care
- Exchange
- ETWO Nasdaq
- CATX Nasdaq
- Market Cap
- ETWO 936.3M
- CATX 782.7M
- IPO Year
- ETWO N/A
- CATX N/A
- Fundamental
- Price
- ETWO $3.03
- CATX $3.50
- Analyst Decision
- ETWO Hold
- CATX Strong Buy
- Analyst Count
- ETWO 3
- CATX 9
- Target Price
- ETWO $3.90
- CATX $20.88
- AVG Volume (30 Days)
- ETWO 1.7M
- CATX 1.9M
- Earning Date
- ETWO 01-07-2025
- CATX 11-12-2024
- Dividend Yield
- ETWO N/A
- CATX N/A
- EPS Growth
- ETWO N/A
- CATX N/A
- EPS
- ETWO N/A
- CATX N/A
- Revenue
- ETWO $619,301,000.00
- CATX $1,557,000.00
- Revenue This Year
- ETWO N/A
- CATX N/A
- Revenue Next Year
- ETWO $3.01
- CATX N/A
- P/E Ratio
- ETWO N/A
- CATX N/A
- Revenue Growth
- ETWO N/A
- CATX N/A
- 52 Week Low
- ETWO $2.89
- CATX $2.30
- 52 Week High
- ETWO $5.08
- CATX $19.10
- Technical
- Relative Strength Index (RSI)
- ETWO 40.28
- CATX 14.59
- Support Level
- ETWO $2.89
- CATX $11.40
- Resistance Level
- ETWO $3.10
- CATX $12.82
- Average True Range (ATR)
- ETWO 0.13
- CATX 0.85
- MACD
- ETWO 0.01
- CATX -0.76
- Stochastic Oscillator
- ETWO 24.11
- CATX 5.67
About ETWO E2open Parent Holdings Inc.Class A
E2open Parent Holdings Inc is an end-to-end and cloud-based supply chain management SaaS platform. The company's software combines networks, data, and applications to provide a deeply embedded, mission-critical platform that allows customers to optimize the supply chain across channel shaping, business planning, logistics, trade, manufacturing, and supply management. The Group has one reportable segment consisting of cloud-based, end-to-end SCM software. Geographically, the company operates in the Americas, Europe, and Asia Pacific, out of which the majority is from the Americas.
About CATX Perspective Therapeutics Inc.
Perspective Therapeutics Inc is a medical technology and radiopharmaceutical company that is pioneering various treatment applications for cancers throughout the body. The Company has a proprietary technology that utilizes the alpha emitting isotope 212Pb to deliver powerful radiation specifically to cancer cells via specialized targeting peptides.